Iterum Therapeutics plc — Director's Dealing 2019

Jun 17, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Iterum Therapeutics plc (ITRM)
CIK: 0001659323
Period of Report: 2019-06-13

Reporting Person: HEALY JAMES (Director, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-06-13	Restricted Stock Units	$	A	5703	Disposed		Ordinary Shares (5703)	Direct

Footnotes

F1: Each restricted stock unit ("RSU") represents the contingent right to receive one ordinary share upon vesting of the RSU.

F2: Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's 2018 Equity Incentive Plan, the RSUs shall vest on June 13, 2020.